Localized Urticaria During Rituximab Infusion for the Treatment of Cutaneous Lymphoid Hyperplasia
Clinical Skin Cancer · 2017-12 · 2 (1-2) · 66-68
DOI: 10.1016/j.clsc.2017.08.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Skin Cancer, 2017-12. Verfasst von Melissa Shive und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shive, M., Dreyer, S. D., Bhatt, M., Madkan, V. K., & Pinter-Brown, L. (2017). Localized Urticaria During Rituximab Infusion for the Treatment of Cutaneous Lymphoid Hyperplasia. Clinical Skin Cancer, 2(1-2), 66-68. https://doi.org/10.1016/j.clsc.2017.08.001
Vancouver
Shive M, Dreyer SD, Bhatt M, Madkan VK, Pinter-Brown L. Localized Urticaria During Rituximab Infusion for the Treatment of Cutaneous Lymphoid Hyperplasia. Clinical Skin Cancer. 2017;2(1-2):66-68. doi:10.1016/j.clsc.2017.08.001
BibTeX
@article{Shive2017,
author = {Shive, Melissa and Dreyer, Sean D. and Bhatt, Mehul and Madkan, Vandana K. and Pinter-Brown, Lauren},
title = {Localized Urticaria During Rituximab Infusion for the Treatment of Cutaneous Lymphoid Hyperplasia},
journal = {Clinical Skin Cancer},
year = {2017},
volume = {2},
number = {1-2},
pages = {66--68},
doi = {10.1016/j.clsc.2017.08.001}
}
EUVIMED